Status
Conditions
Treatments
About
The goal of this observational study is to learn about the long-term effect of surgery in metastatic gastric cancer patients who are accessed as having opportunity for surgery under Multi-disciplinary Team (MDT) evaluation. The main question it aims to answer is:
Does surgery extend survival time in metastatic gastric cancer patients who are accessed as having opportunity for surgery under Multi-disciplinary Team (MDT) evaluation?
Full description
Select metastatic gastric cancer patients that have the opportunity to undergo any forms of surgery through MDT. Then further evaluate these patients' risks and benefits. Let patients make their finally decision through shared-decision making (SDM). According to the actual decision, the patients are divided into surgery group and non-surgery group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
hemoglobin≥90g/L; absolute count of neutral granulocytes (ANC) ≥1.5×10^9/L; platelets≥100×10^9/L; Alt, AST≤ 2.5 times the normal upper limit,≤5 times the normal upper limit value (with liver metastasis); ALP ≤ 2.5 times the normal upper limit,≤5 times the normal upper limit (with liver or bone metastasis); total bilirubin<1.5 times the normal upper limit value of serum; serum creatinine<1.5 times normal upper limit; albumin≥30g/L;
Exclusion criteria
121 participants in 2 patient groups
Loading...
Central trial contact
Xiaotian Zhang, professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal